|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses | ||||
| Research and development | ||||
| General and administrative | ||||
| Placement agent fees, legal costs and other expenses | ||||
| Total operating expenses | ||||
| Net loss from operations | ||||
| Other (Expense) income | ||||
| Interest expense | ||||
| Change in fair value of warrant liability | ||||
| Interest expense | ||||
| Related Party | ||||
| Nonrelated Party | ||||
| Interest expense | ||||
| Related Party | ||||
| Nonrelated Party | ||||
| Interest income | ||||
| Convertible notes finance fee | ||||
| Change in fair value of derivative liabilities | ||||
| Change in fair value of convertible notes | ||||
| Gain on sale of marketable securities | ||||
| Change in fair value of marketable securities | ||||
| Gain on settlement of debt | ||||
| Loss on settlement of convertible debt | ||||
| Total other (expense) income | ||||
| Net loss attributable to common stockholders | ||||
| Net loss | ||||
| Weighted average common shares outstanding - basic | ||||
| Net loss per shares - basic | ||||
| Weighted average common shares outstanding - diluted | ||||
| Net loss per share - diluted | ||||
Loading...